Commercially focussed Chartered & European Patent Attorneys providing intellectual property (IP) services to innovative companies worldwide. Our experienced IP professionals deliver exceptional service and tangible results.
Secerna is a firm of commercially focussed Chartered & European Patent Attorneys. The team operates globally, representing and protecting the interests of multi-national corporations, FTSE and NYSE listed companies, universities, spin-out companies, small businesses and innovators worldwide.
We help our clients create and extract the maximum value from their intellectual property while minimizing costs, advising on the best IP strategies to meet their commercial goals. Our services include:
We represent our clients directly at the UK Intellectual Property Office, European Patent Office, and World International Property Organization in all aspects of intellectual property matters.
We build long-term business relationships with our clients, based on exceptional trust, teamwork and value for money.
We work hand in hand with you to find the best strategies to meet your business goals.
Our team combines considerable technical know-how and sector expertise with extensive commercial acumen.
This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.
Read moreAs of 1 April 2025, the European patent system has expanded its reach into South-East Asia, enabling the validation of European patents in the Lao People's Democratic Republic (Lao PDR). This significant development, facilitated by an agreement with the Lao government, enhances intellectual property protection for businesses operating in the region. The European Patent Office (EPO), which grants these patents, now extends this protection to 46 countries, including its 39 member states and those covered by extension and validation agreements.
Read moreJoin Intellectual Property (IP) specialist Secerna for an insightful webinar: "Why Does Intellectual Property Matter to Your Business?". Delivered by Patent Attorney Melvyn Ansell, this session will equip you with the knowledge to leverage intellectual property (IP) for a real competitive advantage, attract investors, and drive long-term business growth.
Read moreThis series continues to explore the fascinating world of pharmaceuticals. Next up is QUVIVIQ® (from Idorsia Pharamceuticals) is a medicine for treating adults with insomnia (difficulty falling asleep or staying asleep).
Read moreSuccess can be a double-edged sword. Reputation is what all brands strive for, but this can come at a price, and brand owners need to take steps to appropriately ringfence this reputation. If a brand owner does not take the appropriate steps, including protecting and enforcing their trade mark rights, there is a risk of those marks becoming unprotectable generic terms (also known as genericide), subsequently losing their trade mark significance.
Read moreThis series continues to explore the fascinating world of pharmaceuticals. Next up is PAXLOVID® an oral antiviral medication developed by Pfizer to treat mild-to-moderate COVID-19 in adults who are at high risk of progressing to severe illness.
Read more
